T2 Biosystems (TTOO) Priced

Developing diagnostic tests to screen for sepsis and impaired hemostasis.

Health Care - Biotechnology

IPO Performance
Latest Trade $5.55 0.00 (0.0%)
First Day Return 30.2%
Return from IPO -49.5%
 
T2 Biosystems IPO News more
  • .
IPO Data
IPO File Date 07/02/2014
Offer Price $11.00
Price Range $15.00 - $17.00
Offer Shares (mm) 5.2
Deal Size ($mm) 57
 
IPO Data
IPO Date 08/06/2014
Offer Price $11.00
Price Range $15.00 - $17.00
Offer Shares (mm) 5.2
Deal Size ($mm) $57
 
Underwriters
more
Business Overview
Developing diagnostic tests to screen for sepsis and impaired hemostasis.
Developing diagnostic tests to screen for sepsis and impaired hemostasis.
more
Company Data
Headquarters Lexington, MA
Founded 2006
Employees 68
Website www.t2biosystems.com
 

Performance vs. IPO Index (IPOUSA)